MetaCap

Electromed (ELMD) vs Outset Medical (OM)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Electromed (ELMD) has outperformed Outset Medical (OM) over the past year, losing 11.3% versus a loss of 34.5%. Over five years, ELMD leads with a +99.1% price change compared with -99.6% for OM. Electromed is the larger company by market cap ($187.8 million vs $53.0 million), about 3.5 times the size.

Electromed converts more of its revenue into profit, with a net margin of 15.3% versus -68.3%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

ELMD-11.31%OM-34.50%
+84%+22%-40%
Nov 21, 20251 yearNov 20, 2026
ELMD+94.91%OM-99.62%
+307%+94%-119%
Nov 15, 20215 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

ELMD versus OM key metrics
MetricELMDOM
Share price$22.98$2.81
Market cap$187.84M$53.03M
1-day change-1.20%-3.44%
YTD return-21.09%-24.26%
1-year return-11.31%-34.50%
5-year return+99.13%-99.61%
P/E ratio (TTM)16.65—
Forward P/E37.67—
EPS (TTM)$1.38$-3.78
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$73.78M$119.48M
Revenue growth (YoY)+15.28%+5.09%
Net income (latest FY)$11.30M$-81.65M
Gross margin78.54%39.13%
Operating margin18.82%-55.83%
Net margin15.32%-68.34%
52-week high$47.40$6.49
52-week low$22.67$2.77
Distance from 52-week high-51.52%-56.70%
Analyst consensusstrong_buybuy
Avg. price target upside+111.05%+172.95%
Average volume83.59K140.40K
Shares outstanding8.17M18.87M
Employees195310
SectorHealth CareHealth Care
IndustryBiotechnology: Electromedical & Electrotherapeutic ApparatusBiotechnology: Electromedical & Electrotherapeutic Apparatus

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • Electromed is about 3.5 times larger than Outset Medical by market value ($187.84M vs $53.03M).
  • ELMD has outperformed OM by 23.2 percentage points over the past year.
  • Electromed is more profitable, keeping 15.3 cents of every revenue dollar as net income versus -68.3 cents for Outset Medical.
  • Electromed grew revenue faster in its latest fiscal year (+15.28% vs +5.09%).

About Electromed

ELMD stock →

Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients in the United States and internationally.

Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus · 195 employees

About Outset Medical

OM stock →

Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company provides Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables.

Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus · 310 employees

ELMD vs OM FAQ

Which is bigger, Electromed or Outset Medical?

Electromed (ELMD) is larger, with a market capitalization of $187.84M compared with $53.03M for Outset Medical (OM).

Which stock has performed better over the past year, ELMD or OM?

ELMD returned -11.31% over the past 12 months, compared with -34.50% for OM (price return, excluding dividends). Past performance does not predict future results.

Are Electromed and Outset Medical in the same industry?

Yes. Both are classified in the Biotechnology: Electromedical & Electrotherapeutic Apparatus industry within the Health Care sector.

More comparisons